Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cervical cancer screening, screening errors and reporting.

V Schneider, M R Henry, M Jimenez-Ayala

    Acta Cytologica
    |August 2, 2001
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Effects of β-casein A1/A2 milk and β- and κ-casein genotypes on the performance, body composition, and fecal score of dairy calves.

    Scientific reports·2025
    Same author

    Training in movement disorders during neurology residency in France: A national survey on educational gaps and future perspectives.

    Revue neurologique·2025
    Same author

    Effect of β-casein A1 or A2 milk on body composition, milk intake, and growth in Holstein, Simmental, and crossbred dairy calves of both sexes.

    Journal of dairy science·2024
    Same author

    Behavioral and physiological responses to an inspired-air supplemental cooling system for dairy cows in free-stall housing.

    Animal : an international journal of animal bioscience·2023
    Same author

    Neurodegeneration, oxidative stress and lipid metabolism plasma biomarkers to differentiate Parkinson's disease from atypical parkinsonian syndromes.

    Revue neurologique·2023
    Same author

    Dairy cow hoof impact and slide measurements for common Ontario dairy farm floorings.

    Journal of dairy science·2023
    Same journal

    The Development Path of Gynecological Cytology after Papanicolaou: from Bethesda to Artificial Intelligence and Personalized Medicine.

    Acta cytologica·2026
    Same journal

    Cytological Features of CIC-rearranged Sarcoma. A Report of 5 New Cases and Review of the Literature.

    Acta cytologica·2026
    Same journal

    Pericardial Fluid Metastatic Tumor Distribution and Fluid Volume Analysis, a 10-Year Institutional Experience.

    Acta cytologica·2026
    Same journal

    The cytopathology of infectious disease: A review.

    Acta cytologica·2026
    Same journal

    Investigation of a storage method for peritoneal and pleural effusion cytology specimens for long-term preservation of antigenicity in immunocytochemical staining.

    Acta cytologica·2026
    Same journal

    Diagnostic Utility of endoscopic crush cytology in gastrointestinal malignancies.

    Acta cytologica·2026
    See all related articles

    Cervical cancer screening significantly reduced cancer rates. However, most remaining deaths occur in underserved regions due to incomplete screening coverage, not screening errors.

    Area of Science:

    • Oncology
    • Public Health
    • Preventive Medicine

    Background:

    • Cervical carcinoma screening via cervicovaginal cytology has dramatically decreased incidence and mortality over 50 years.
    • This represents the most successful cancer prevention program globally.
    • Current challenges highlight that 80% of cervical cancer incidence and mortality occur in underserved, underscreened populations.

    Framework:

    • Successful cervical cancer screening programs require high population coverage.
    • Regular screening intervals are crucial.
    • Well-trained clinical and laboratory personnel are essential.
    • An efficient follow-up and treatment system is a key component.

    Implementation:

    • Deficiencies in coverage, regularity, staff training, or follow-up can lead to screening system failures.

    Related Experiment Videos

  • Lack of complete coverage is the primary reason for persistent cervical cancer mortality in developed nations.
  • The effectiveness of new, costly technologies is questionable without improved screening coverage.

    • Implications:

    • Addressing the remaining cervical cancer burden necessitates improving screening coverage rates, particularly in underserved areas.
    • Screening errors, while they occur, are a minor factor in overall screening failures.
    • A unified global terminology for cervical cancer screening is not currently feasible due to existing diverse systems.